{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:18:57Z","timestamp":1787653137356,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"DOI":"10.1007\/s11886-026-02410-3","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T09:26:04Z","timestamp":1787649964000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Medication Non-Adherence in Resistant Hypertension: Detection, Drivers, and Practical Solutions"],"prefix":"10.1007","volume":"28","author":[{"given":"Sudheesha","family":"Perera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5928-4525","authenticated-orcid":false,"given":"Benjamin D.","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"issue":"2","key":"2410_CR1","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/ajh\/hpae141","volume":"38","author":"ST Hardy","year":"2024","unstructured":"Hardy ST, Jaeger BC, Foti K, Ghazi L, Wozniak G, Muntner P. Trends in blood pressure control among US adults with hypertension, 2013\u20132014 to 2021\u20132023. Am J Hypertens. 2024;38(2):120\u20138.","journal-title":"Am J Hypertens"},{"issue":"10","key":"2410_CR2","first-page":"e212","volume":"82","author":"DW Jones","year":"2025","unstructured":"Jones DW, Ferdinand KC, Taler SJ, Johnson HM, Shimbo D et al. 2025 AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM Guideline for the prevention, detection, evaluation and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Hypertension. 2025;82(10):e212\u2013e316.","journal-title":"Hypertension"},{"issue":"1","key":"2410_CR3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/HYP.0000000000000203","volume":"79","author":"NK Choudhry","year":"2022","unstructured":"Choudhry NK, Kronish IM, Vongpatanasin W, Ferdinand KC, Pavlik VN, Egan BM, et al. Medication adherence and blood pressure control: a scientific statement from the American Heart Association. Hypertension. 2022;79(1):e1\u201314.","journal-title":"Hypertension"},{"issue":"5","key":"2410_CR4","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1161\/HYP.0000000000000084","volume":"72","author":"RM Carey","year":"2018","unstructured":"Carey RM, Calhoun DA, Bakris GL, Brook RD, Daugherty SL, Dennison-Himmelfarb CR, et al. Resistant hypertension: detection, evaluation, and management: a scientific statement from the American Heart Association. Hypertension. 2018;72(5):e53\u201390.","journal-title":"Hypertension"},{"issue":"1","key":"2410_CR5","first-page":"99","volume":"84","author":"MC Acelajado","year":"2024","unstructured":"Acelajado MC, Hughes ZH, Oparil S, Calhoun DA. Evaluation and management of resistant hypertension: core curriculum 2024. Am J Kidney Dis. 2024;84(1):99\u2013110.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"2410_CR6","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1097\/HJH.0b013e32835e2286","volume":"31","author":"O Jung","year":"2013","unstructured":"Jung O, Gechter JL, Wunder C, Paulke A, Bartel C, Geiger H, et al. Resistant hypertension? Assessment of adherence by toxicological urine analysis. J Hypertens. 2013;31(4):766\u201374.","journal-title":"J Hypertens"},{"issue":"11","key":"2410_CR7","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1136\/heartjnl-2013-305063","volume":"100","author":"M Tomaszewski","year":"2014","unstructured":"Tomaszewski M, White C, Patel P, Masca N, Damani R, Hepworth J, et al. High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS\/MS) urine analysis. Heart. 2014;100(11):855\u201361.","journal-title":"Heart"},{"issue":"1","key":"2410_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1161\/HYPERTENSIONAHA.121.17596","volume":"79","author":"D Lane","year":"2022","unstructured":"Lane D, Lawson A, Burns A, Azizi M, Burnier M, Jones DJL, et al. Nonadherence in hypertension: how to develop and implement chemical adherence testing. Hypertension. 2022;79(1):12\u201323.","journal-title":"Hypertension"},{"issue":"7","key":"2410_CR9","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1093\/ajh\/hpad013","volume":"36","author":"G Bourque","year":"2023","unstructured":"Bourque G, Ilin JV, Ruzicka M, Hundemer GL, Shorr R, Hiremath S. Nonadherence is common in patients with apparent resistant hypertension: a systematic review and meta-analysis. Am J Hypertens. 2023;36(7):394\u2013403.","journal-title":"Am J Hypertens"},{"issue":"8","key":"2410_CR10","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.jacc.2013.10.067","volume":"63","author":"S Brinker","year":"2014","unstructured":"Brinker S, Pandey A, Ayers C, Price A, Raheja P, Arbique D, et al. Therapeutic drug monitoring facilitates blood pressure control in resistant hypertension. J Am Coll Cardiol. 2014;63(8):834\u20135.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2410_CR11","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1161\/HYPERTENSIONAHA.116.08818","volume":"69","author":"RL de Jager","year":"2017","unstructured":"de Jager RL, de Beus E, Beeftink MM, Sanders MF, Vonken EJ, Voskuil M, et al. Impact of medication adherence on the effect of renal denervation: the sympathy Trial. Hypertension. 2017;69(4):678\u201384.","journal-title":"Hypertension"},{"issue":"6s2","key":"2410_CR12","doi-asserted-by":"publisher","first-page":"S172","DOI":"10.1016\/j.amepre.2017.07.014","volume":"53","author":"C Park","year":"2017","unstructured":"Park C, Fang J, Hawkins NA, Wang G. Comorbidity status and annual total medical expenditures in U.S. hypertensive adults. Am J Prev Med. 2017;53(6s2):S172\u201381.","journal-title":"Am J Prev Med"},{"key":"2410_CR13","doi-asserted-by":"publisher","first-page":"1452464","DOI":"10.3389\/fphar.2024.1452464","volume":"15","author":"S Halpin","year":"2024","unstructured":"Halpin S, Konje V, Brettle M, Wright H. Chemical adherence testing in the clinical management of hypertension: a scoping review. Front Pharmacol. 2024;15:1452464.","journal-title":"Front Pharmacol"},{"issue":"5","key":"2410_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/ajh\/hpad118","volume":"37","author":"FEM Fadl Elmula","year":"2024","unstructured":"Fadl Elmula FEM, Mariampillai JE, Heimark S, Kjeldsen SE, Burnier M. Medical measures in hypertensives considered resistant. Am J Hypertens. 2024;37(5):307\u201317.","journal-title":"Am J Hypertens"},{"issue":"11","key":"2410_CR15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s11906-020-01105-6","volume":"22","author":"B Kably","year":"2020","unstructured":"Kably B, Billaud EM, Boutouyrie P, Azizi M. Is there any hope for monitoring adherence in an efficient and feasible way for resistant hypertension diagnosis and follow-up? Curr Hypertens Rep. 2020;22(11):96.","journal-title":"Curr Hypertens Rep"},{"issue":"5","key":"2410_CR16","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1097\/HJH.0000000000000503","volume":"33","author":"BD Gallagher","year":"2015","unstructured":"Gallagher BD, Muntner P, Moise N, Lin JJ, Kronish IM. Are two commonly used self-report questionnaires useful for identifying antihypertensive medication nonadherence? J Hypertens. 2015;33(5):1108\u201313.","journal-title":"J Hypertens"},{"issue":"11","key":"2410_CR17","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1291\/hypres.31.2037","volume":"31","author":"A Zeller","year":"2008","unstructured":"Zeller A, Ramseier E, Teagtmeyer A, Battegay E. Patients\u2019 self-reported adherence to cardiovascular medication using electronic monitors as comparators. Hypertens research: official J Japanese Soc Hypertens. 2008;31(11):2037\u201343.","journal-title":"Hypertens research: official J Japanese Soc Hypertens"},{"key":"2410_CR18","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/1472-6963-12-270","volume":"12","author":"J Meddings","year":"2012","unstructured":"Meddings J, Kerr EA, Heisler M, Hofer TP. Physician assessments of medication adherence and decisions to intensify medications for patients with uncontrolled blood pressure: still no better than a coin toss. BMC Health Serv Res. 2012;12:270.","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"2410_CR19","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1161\/HYPERTENSIONAHA.117.09631","volume":"70","author":"P Gupta","year":"2017","unstructured":"Gupta P, Patel P, \u0160trauch B, Lai FY, Akbarov A, Gulsin GS, et al. Biochemical screening for nonadherence is associated with blood pressure reduction and improvement in adherence. Hypertension. 2017;70(5):1042\u20138.","journal-title":"Hypertension"},{"issue":"1","key":"2410_CR20","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/HJH.0000000000003585","volume":"42","author":"LEJ Peeters","year":"2024","unstructured":"Peeters LEJ, Kappers MHW, Hesselink DA, van der Net JB, Hartong SCC, van de Laar R, et al. Antihypertensive drug concentration measurement combined with personalized feedback in resistant hypertension: a randomized controlled trial. J Hypertens. 2024;42(1):169\u201378.","journal-title":"J Hypertens"},{"issue":"12","key":"2410_CR21","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstrom M, Burnier M, Grassi G, Januszewicz A. 2023 ESH Guidelines for the management of arterial hypertension. J Hypertens. 2023;41(12):1874\u20132071.","journal-title":"J Hypertens"},{"issue":"2","key":"2410_CR22","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1161\/HYPERTENSIONAHA.120.15781","volume":"77","author":"G Parati","year":"2021","unstructured":"Parati G, Kjeldsen S, Coca A, Cushman WC, Wang J. Adherence to single-pill versus free-equivalent combination therapy in hypertension: a systematic review and meta-analysis. Hypertension. 2021;77(2):692\u2013705.","journal-title":"Hypertension"},{"issue":"6","key":"2410_CR23","doi-asserted-by":"publisher","first-page":"e1002584","DOI":"10.1371\/journal.pmed.1002584","volume":"15","author":"AA Verma","year":"2018","unstructured":"Verma AA, Khuu W, Tadrous M, Gomes T, Mamdani MM. Fixed-dose combination antihypertensive medications, adherence, and clinical outcomes: A population-based retrospective cohort study. PLoS Med. 2018;15(6):e1002584.","journal-title":"PLoS Med"},{"issue":"5","key":"2410_CR24","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1161\/HYPERTENSIONAHA.122.20810","volume":"80","author":"RE Schmieder","year":"2023","unstructured":"Schmieder RE, Wassmann S, Predel HG, Weisser B, Blettenberg J, Gillessen A, et al. Improved persistence to medication, decreased cardiovascular events and reduced all-cause mortality in hypertensive patients with use of single-pill combinations: results from the start-study. Hypertension. 2023;80(5):1127\u201335.","journal-title":"Hypertension"},{"issue":"3","key":"2410_CR25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/HJH.0000000000003916","volume":"43","author":"G Simonyi","year":"2025","unstructured":"Simonyi G, Burnier M, Narkiewicz K, Rokszin G, Abonyi-Toth Z, Kovacs G, et al. Effect of single-pill versus free equivalent combinations on persistence and major adverse cardiovascular events in hypertension: a real-world analysis. J Hypertens. 2025;43(3):405\u201312.","journal-title":"J Hypertens"},{"key":"2410_CR26","doi-asserted-by":"publisher","unstructured":"King JB, An J, Bellows BK, Cohen JB, Commodore-Mensah Y, Ghazi L, Langford AT, Brook RD, American Heart Association Council on Hypertension; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology. Single-Pill Combination Therapy for the Management of Hypertension: A Scientific Statement From the American Heart Association. Hypertension. 2026 Mar. 83(3):e00258. https:\/\/doi.org\/10.1161\/HYP.0000000000000258","DOI":"10.1161\/HYP.0000000000000258"},{"issue":"24","key":"2410_CR27","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1016\/j.jacc.2024.08.025","volume":"84","author":"A Rodgers","year":"2024","unstructured":"Rodgers A, Salam A, Schutte AE, Cushman WC, de Silva HA, Di Tanna GL, et al. Efficacy and safety of a novel low-dose triple single-pill combination compared with placebo for initial treatment of hypertension. J Am Coll Cardiol. 2024;84(24):2393\u2013403.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2410_CR28","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1038\/s41440-024-01658-y","volume":"47","author":"MD Huffman","year":"2024","unstructured":"Huffman MD, Baldridge AS, Lazar D, Abbas H, Mejia J, Flowers FM, et al. Efficacy and safety of a four-drug, quarter-dose treatment for hypertension: the QUARTET USA randomized trial. Hypertens Res. 2024;47(6):1668\u201377.","journal-title":"Hypertens Res"},{"issue":"10506","key":"2410_CR29","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/S0140-6736(25)00991-2","volume":"406","author":"N Wang","year":"2025","unstructured":"Wang N, Salam A, Pant R, Kumar A, Dhurjati R, Haghdoost F, et al. Blood pressure-lowering efficacy of antihypertensive drugs and their combinations: a systematic review and meta-analysis of randomised, double-blind, placebo-controlled trials. Lancet. 2025;406(10506):915\u201325.","journal-title":"Lancet"},{"key":"2410_CR30","first-page":"CD011851","volume":"3","author":"K Palmer","year":"2024","unstructured":"Palmer K, Bschaden A, Stroebele-Benschop N. Mobile phone text messaging for medication adherence in secondary prevention of cardiovascular disease. Cochrane Database Syst Reviews. 2024;3:CD011851.","journal-title":"Cochrane Database Syst Reviews"},{"issue":"6","key":"2410_CR31","doi-asserted-by":"publisher","first-page":"e005624","DOI":"10.1161\/CIRCOUTCOMES.118.005624","volume":"12","author":"BK Bellows","year":"2019","unstructured":"Bellows BK, Ruiz-Negr\u00f3n N, Bibbins-Domingo K, King JB, Pletcher MJ, Moran AE, et al. Clinic-based strategies to reach United states million hearts 2022 blood pressure control goals. Circulation Cardiovasc Qual outcomes. 2019;12(6):e005624.","journal-title":"Circulation Cardiovasc Qual outcomes"},{"issue":"14","key":"2410_CR32","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1056\/NEJMoa2507109","volume":"393","author":"JM Flack","year":"2025","unstructured":"Flack JM, Azizi M, Brown JM, Dwyer JP, Fronczek J, Jones ESW, et al. Efficacy and safety of baxdrostat in uncontrolled and resistant hypertension. N Engl J Med. 2025;393(14):1363\u201374.","journal-title":"N Engl J Med"},{"key":"2410_CR33","unstructured":"Williams B, Flack JM, Azizi M, Dwyer JP, Jones ESW, Olsson DS. Effect of Baxdrostat on 24-hour ambulatory blood pressure in patients with resistant hypertension (bax24): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet. 2026."},{"issue":"10367","key":"2410_CR34","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1016\/S0140-6736(22)02034-7","volume":"400","author":"MP Schlaich","year":"2022","unstructured":"Schlaich MP, Bellet M, Weber MA, Danaietash P, Bakris GL, Flack JM, et al. Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial. Lancet. 2022;400(10367):1927\u201337.","journal-title":"Lancet"},{"issue":"10532","key":"2410_CR35","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/S0140-6736(25)02064-1","volume":"407","author":"M Azizi","year":"2026","unstructured":"Azizi M, Tuttle KR, Brown JM, Piskorz DL, Kario K, Williams B. New drug therapies for hypertension. Lancet. 2026;407(10532):1014\u201328.","journal-title":"Lancet"},{"issue":"20","key":"2410_CR36","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1016\/j.jacc.2024.03.382","volume":"83","author":"MJ Koren","year":"2024","unstructured":"Koren MJ, Rodriguez F, East C, Toth PP, Watwe V, Abbas CA, et al. An inclisiran first strategy vs usual care in patients with atherosclerotic cardiovascular disease. J Am Coll Cardiol. 2024;83(20):1939\u201352.","journal-title":"J Am Coll Cardiol"},{"issue":"9294","key":"2410_CR37","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/S0140-6736(01)06710-1","volume":"358","author":"RS Vasan","year":"2001","unstructured":"Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet. 2001;358(9294):1682\u20136.","journal-title":"Lancet"},{"issue":"1","key":"2410_CR38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1161\/HYPERTENSIONAHA.111.189100","volume":"60","author":"M Gurven","year":"2012","unstructured":"Gurven M, Blackwell AD, Rodr\u00edguez DE, Stieglitz J, Kaplan H. Does blood pressure inevitably rise with age? longitudinal evidence among forager-horticulturalists. Hypertension. 2012;60(1):25\u201333.","journal-title":"Hypertension"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-026-02410-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-026-02410-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-026-02410-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T09:26:05Z","timestamp":1787649965000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-026-02410-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2410"],"URL":"https:\/\/doi.org\/10.1007\/s11886-026-02410-3","relation":{},"ISSN":["1534-3170"],"issn-type":[{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"6 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AI was not used in the preparation of this manuscript.","order":3,"name":"Ethics","label":"Use of Artificial Intelligence","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"81"}}